OSSDSIGN Cranial on display at CNS Annual Meeting in Boston, October 7-11.
OSSDSIGN Cranial on display at the AANS in Los Angeles, April 22-26.
Uppsala 2/2/2017. OssDsign AB has signed an agreement with Matador Medical Inc. to act as its master distributor in the US market.
We are looking forward to meet you at the following events during 2017.
Strengthens organization ahead of the US Launch of its Novel Regenerative Facial and Cranial Implants in 2017
We are looking forward to meet you at the following events during 2016.
OssDsign AB today announced that the company has received CE mark approval for its bio-ceramic burr hole plug - Cranioplug.
OssDsign AB today announced that it has successfully raised SEK 93 million (EUR 9.6 million), in a new equity financing.
In the News:
WHAT’S THE PROBLEM? - NATIONAL REGISTRIES AIM TO IMPROVE CRANIOPLASTY
THE EVOLUTION OF CRANIAL IMPLANT MATERIALS - FROM REPAIR TOWARDS REGENERATION
STOCKHOLM - October 20, 2014. OssDsign AB today announced that its bioceramic burr hole plug - Cranioplug - has received 510(k) clearance by the US Food and Drug Administration (FDA). Karolinska Development has a 26 percent ownership in OssDsign.